Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis
- PMID: 20566590
- DOI: 10.1530/EJE-10-0419
Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis
Abstract
Objective: The type 2 deiodinase (D2) is a key enzyme for intracellular triiodothyronine (T(3)) generation. A single-nucleotide polymorphism in D2 (Thr92Ala) has been associated with increased insulin resistance in nondiabetic and type 2 diabetes (DM2) subjects. Our aim was to evaluate whether the D2 Thr92Ala polymorphism is associated with increased risk for DM2.
Design and methods: A case-control study with 1057 DM2 and 516 nondiabetic subjects was performed. All participants underwent genotyping of the D2 Thr92Ala polymorphism. Additionally, systematic review and meta-analysis of the literature for genetic association studies of D2 Thr92Ala polymorphism and DM2 were performed in Medline, Embase, LiLacs, and SciELO, and major meeting databases using the terms 'rs225014' odds ratio (OR) 'thr92ala' OR 'T92A' OR 'dio2 a/g'.
Results: In the case-control study, the frequencies of D2 Ala92Ala homozygous were 16.4% (n=173) versus 12.0% (n=62) in DM2 versus controls respectively resulting in an adjusted OR of 1.41 (95% confidence intervals (CI) 1.03-1.94, P=0.03). The literature search identified three studies that analyzed the association of the D2 Thr92Ala polymorphism with DM2, with the following effect estimates: Mentuccia (OR 1.40 (95% CI 0.78-2.51)), Grarup (OR 1.09 (95% CI 0.92-1.29)), and Maia (OR 1.22 (95% CI 0.78-1.92)). The pooled effect of the four studies resulted in an OR 1.18 (95% CI 1.03-1.36, P=0.02).
Conclusions: Our results indicate that in a case-control study, the homozygosity for D2 Thr92Ala polymorphism is associated with increased risk for DM2. These results were confirmed by a meta-analysis including 11 033 individuals, and support a role for intracellular T(3) concentration in skeletal muscle on DM2 pathogenesis.
Similar articles
-
Clinical significance of type 2 iodothyronine deiodinase polymorphism.Expert Rev Endocrinol Metab. 2018 Sep;13(5):273-277. doi: 10.1080/17446651.2018.1523714. Epub 2018 Sep 27. Expert Rev Endocrinol Metab. 2018. PMID: 30257587 Review.
-
The Type 2 Deiodinase Thr92Ala Polymorphism Is Associated with Worse Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.J Diabetes Res. 2016;2016:5928726. doi: 10.1155/2016/5928726. Epub 2016 Sep 29. J Diabetes Res. 2016. PMID: 27777960 Free PMC article. Review.
-
Type 2 deiodinase Thr92Ala polymorphism is associated with disrupted placental activity but not with dysglycemia or adverse gestational outcomes: a genetic association study.Fertil Steril. 2014 Mar;101(3):833-9. doi: 10.1016/j.fertnstert.2013.11.018. Epub 2013 Dec 17. Fertil Steril. 2014. PMID: 24355051
-
The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density.J Bone Miner Res. 2010 Jun;25(6):1385-91. doi: 10.1002/jbmr.27. J Bone Miner Res. 2010. PMID: 20200941
-
The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus.J Clin Endocrinol Metab. 2005 Jun;90(6):3472-8. doi: 10.1210/jc.2004-1977. Epub 2005 Mar 29. J Clin Endocrinol Metab. 2005. PMID: 15797963
Cited by
-
Determination of Frequency of Type 2 Deiodinase Thr92Ala Polymorphism (rs225014) in 131I-treated Differentiated Thyroid Cancer Patients Undertaking L-thyroxine (L-T4) Suppression Therapy.Indian J Nucl Med. 2024 Jan-Feb;39(1):24-28. doi: 10.4103/ijnm.ijnm_120_23. Epub 2024 Mar 27. Indian J Nucl Med. 2024. PMID: 38817730 Free PMC article.
-
The recent advances and future perspectives of genetic compensation studies in the zebrafish model.Genes Dis. 2022 Jan 5;10(2):468-479. doi: 10.1016/j.gendis.2021.12.003. eCollection 2023 Mar. Genes Dis. 2022. PMID: 37223518 Free PMC article. Review.
-
The Physiological Functions and Polymorphisms of Type II Deiodinase.Endocrinol Metab (Seoul). 2023 Apr;38(2):190-202. doi: 10.3803/EnM.2022.1599. Epub 2023 Apr 27. Endocrinol Metab (Seoul). 2023. PMID: 37150515 Free PMC article. Review.
-
Association of Type 2 Deiodinase Thr92Ala Polymorphism with Pediatric Obesity in Japanese Children: A Case-Control Study.Children (Basel). 2022 Sep 20;9(10):1421. doi: 10.3390/children9101421. Children (Basel). 2022. PMID: 36291357 Free PMC article.
-
Selenium and Selenoproteins at the Intersection of Type 2 Diabetes and Thyroid Pathophysiology.Antioxidants (Basel). 2022 Jun 16;11(6):1188. doi: 10.3390/antiox11061188. Antioxidants (Basel). 2022. PMID: 35740085 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical